NCT02806973 - A Study of Single or Repeated Doses of Glucagon in Participants With Diabetes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Interventions

DRUG

Nasal Glucagon

Administered intranasally.

Trial Locations (1)

H3P 3P1

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Mount Royal